FRANKFURT, Sept 5 (Reuters) – German drugmaker Merck KGaA is considering selling its 860 million-euro ($1.02 billion) consumer health business to focus on science and technology, it said on Tuesday.
“We expect increasing internal constraints to fund the business to reach the required scale. Fully anticipating this, we are preparing strategic options,” Belen Garijo, chief executive of the healthcare business, said in a statement.
$1 = 0.8400 euros
Reporting by Georgina Prodhan; Editing by Maria Sheahan